Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein R is an RNA-binding protein encoded by the HNRNPR gene, member of the hnRNP family, primarily localized in the nucleus but also involved in transporting specific mRNAs (notably β-actin mRNA) to axons in neurons[1][7]. It contains three RNA recognition motif (RRM) domains and a nuclear localization signal, binds to heterogeneous nuclear RNA (hnRNA), and is essential for the regulation of mRNA processing, axonal growth, and neuronal differentiation[1][7]. HNRNPR interacts with proteins including SMN1, PRMT1, TDP-43, and FUS/TLS, many of which are implicated in disorders like ALS and other neurodegenerative diseases[1][7]. Although not a primary drug target or biomarker, altered regulation or mutation of HNRNPR and its partners is associated with neurodegenerative pathology and emerging evidence suggests possible roles in cancer[2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein R (HNRNPR).